Neuron23 is a Biotech company based in South San Francisco, California. It has raised $214M in total funding. Latest round: Series D.
Neuron23 funding overview
Neuron23 is a Biotech company based in South San Francisco, California. Neuron23 has raised $214M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D. Investors on record include SoftBank Vision Fund 2, Westlake Village BioPartners, Kleiner Perkins, Redmile Group, Cowen Healthcare Investments, Acorn Bioventures and 3 others. 9 distinct backers are named across the disclosed rounds.
Neuron23 at a glance
Total raised
$214M
Latest round
Series D
Industry
Biotech
Headquarters
South San Francisco, California
Notable investors
SoftBank Vision Fund 2, Westlake Village BioPartners, Kleiner Perkins, Redmile Group, Cowen Healthcare Investments, Acorn Bioventures, HBM Partners, Perceptive Advisors
Frequently asked about Neuron23 funding
How much has Neuron23 raised?
Neuron23 has raised $214M in total disclosed funding across the rounds on record.
Who has invested in Neuron23?
SoftBank Vision Fund 2, Westlake Village BioPartners, Kleiner Perkins, Redmile Group, Cowen Healthcare Investments, Acorn Bioventures are named among the investors backing Neuron23.
What was the latest Neuron23 funding round?
The most recent disclosed round is a Series D.
Where is Neuron23 based?
Neuron23 is based in South San Francisco, California.
What sector does Neuron23 operate in?
Neuron23 is tracked under Biotech from South San Francisco, California, with $214M in disclosed funding.
Totals shown for Neuron23 aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in South San Francisco and the investors behind them below.
